Guangxi Wuzhou Zhongheng Group Co., Ltd. Class ASSE: 600252

Announcement on Acquisition of a Drug Technology (Patent Right) for the Treatment of Chronic Heart Failure by a Wholly-owned Subsidiary and Signing of the Technology (Patent Right) Transfer Agreement

· Issued by Guangxi Wuzhou Zhongheng Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Acquisition of a Drug Technology (Patent Right) for the Treatment of Chronic Heart Failure by a Wholly-owned Subsidiary and Signing of the Technology (Patent Right) Transfer Agreement

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis